Program Overview
Abridged Program
Wednesday, 14 February 2024
9:00 am – 6:30 pm CET (Check-In: 8:00 pm CET)
Thursday, 15 February 2024
9:00 am – 6:30 pm CET (Conference Dinner: 8:30 pm CET)
Friday, 16 February 2024
9:00 am – 6:30 pm CET
Detailed Program
Day 1 – Wednesday, 14 February 2024
08:00-09:00 |
Check-In |
|
09:00-09:15 |
Opening Ceremony |
|
S1. General Topics in Virology (Part 1)chaired by Albert Bosch and Eric Freed |
||
| 09:15-10:00 | Charlie Rice Keynote Speaker |
A Cure for Hepatitis C, Now What? |
| 10:00-10:45 | Luis Enjuanes Keynote Speaker |
Design of RNA Replicons as Vaccines for Human Pathogenic Coronaviruses, and of Antivirals to Protect From Their Infection |
10:45-11:15 |
Coffee Break |
|
S1. General Topics in Virology (Part 2)chaired by Shan-Lu Liu |
||
| 11:15-11:45 | Carolien van de Sandt Invited Speaker |
Dynamics of CD8+ T Cell Immunity to Circulating and Pandemic Viruses |
| 11:45-12:00 | Silvi Rouskin | Decoding RNA Structures for Insights into Viral Life Cycle Dynamics |
| 12:00-12:15 | Jesús Urquiza López | Identification of a potential entry fusion complex based on sequence homology of African swine fever and Vaccinia virus |
| 12:15-12:30 | Albert Carcereny | Comprehensive Analysis of SARS-CoV-2 Variant Outcompetition Dynamics Through Water-Based Epidemiology |
| 12:30-12:45 | Shruti Chowdhari | HBV-miR-3 tweaks hepatocyte lipid metabolism: Novel insights into HBV pathogenesis |
| 12:45-13:00 | David García-Pedemonte | Human enterovirus and poliovirus diversity assessment using Next-Generation Sequencing: A wastewater-based epidemiology study in Catalonia, Spain (2022-2024) |
13:00-14:30 |
Lunch Break |
|
S2. Antiviral Therapeutics, Vaccines, and Host Defenses (Part 1)chaired by Daniel DiMaio |
||
| 14:30-15:00 | Eric Freed Invited Speaker |
Neutral Sphingomyelinase 2 is Required for HIV-1 Maturation |
| 15:00-15:15 | Alan Cochrane | Putting a Kink in HIV-1 Particle Assembly: Rocaglamide inhibits HIV-1 replication by altering the Gag–genomic RNA interaction |
| 15:15-15:30 | Sneha sree Mullapudi | Nucleocapsid-specific monoclonal antibodies with cross-reactivity to diverse betacoronaviruses as diagnostic tools for future zoonotic spillovers |
| 15:30-15:45 | Dorjbal Dorjsuren | Identification of Novel Small Molecule Inhibitors for Rabies Virus |
| 15:45-16:00 | Victoria Castro | Epithelial–mesenchymal transition transcriptional traits after persistent hepatitis C virus infection elimination by direct-acting antivirals in cell culture |
16:00-16:30 |
Coffee Break |
|
S2. Antiviral Therapeutics, Vaccines, and Host Defenses (Part 2)chaired by Chris Broder |
||
| 16:30-17:00 | Nic Stonehouse Invited Speaker |
Virus-Like Particles as a Next-Generation Vaccine Against Polio |
| 17:00-17:15 | Brian Schaefer | Control of CNS-resident lyssavirus infection by peripherally administered human monoclonal antibodies F11 and A6 |
| 17:15-17:30 | Santseharay Ramirez Almeida | High activity of remdesivir and other broad-spectrum antivirals against multidrug-resistant hepatitis C virus in vitro |
| 17:30-17:45 | Claire Huang | Protection afforded from two mRNA vaccine candidates in a lethal mouse Heartland virus infection challenge model |
| 17:45-18:00 | Adam Sychla | A high-throughput investigation of genetic design constraints in domesticated Influenza A Virus for transient gene delivery |
Flash Poster Presentation Sessionchaired by Gabriel Parra |
||
| 18:00-18:30 | Francesca Magari | New insights into the Antiviral Activity and Mode of Action of Pateamines |
| Nicole Bracci | SARS-CoV-2 Endoribonuclease Antagonizes Antiviral Signaling | |
| Judith Reyes Ballista | Chikungunya Virus Release Rate is Decreased by Phosphatidylserine Receptors | |
| Caitlin Woodson | Development and characterization of a neurological sequelae mouse model for EEEV infection | |
| Nusa Brisar | Utilising engineered filamentous bacteriophages as an innovative antigen delivery platform combined with adjuvant gene electrotransfer of IL-12 plasmid effectively eradicated aggressive murine melanoma | |
| Laura Weber | The double life of lipid droplets: New functions in antiviral innate immune defense | |
| Matty Allan | Long-range RNA:RNA base pairing regulates active conformations of frameshift stimulating elements in coronaviruses | |
| Ashley Nutsford | Identification of a Secreted Form of the Rotavirus Outer Capsid Protein VP7 | |
| Shuhei Tagawa | Host Hsp70 chaperone network participates in the particle formation of SFTSV | |
Day 2 – Thursday, 15 February 2024
S3. Antiviral Innate Immunitychaired by Don Gammon |
||
| 09:00-09:30 | Melanie Brinkmann Invited Speaker |
In the Spotlight: HCMV Immune Evasins Reveal an Antiviral Function of Bone Morphogenetic Protein 9 |
| 09:30-09:45 | Don Gammon | Discovery of an Interferon-Independent Antiviral Pathway and its Antagonism by Poxviruses |
| 09:45-10:00 | Clayton Otter | What makes a common cold virus? Respiratory viruses differentially interface with host interferon responses in the nasal epithelium |
| 10:00-10:15 | Karen Mossman | Differential innate antiviral signaling in human and bat cells |
| 10:15-10:30 | Eugenia Bardossy | A new job for an old friend: Hsc70-4 localizes at the cell surface to mediate the internalization of dsRNA in Drosophila melanogaster |
| 10:30-11:00 | Wolfram Brune Invited Speaker |
A Cytomegalovirus Inflammasome Inhibitor Reduces Proinflammatory Cytokine Release and Pyroptosis |
11:00-11:30 |
Coffee Break & Conference Group Photo |
|
S4. Structure and Mechanisms of Virus Replication (Part 1)chaired by Mark Harris |
||
| 11:30-12:00 | Mikael Skurnik Invited Speaker |
The Enigmatic Yersinia Jumbo Bacteriophage YerA41 |
| 12:00-12:15 | Jamil Saad | Structural basis for Gag assembly and Env incorporation into HIV-1 particles |
| 12:15-12:30 | Rebekah Gullberg | SARS-CoV-2 Virus-Like Particles reveal chaperones of viral assembly |
| 12:30-13:00 | Margaret Kielian Invited Speaker |
Alphavirus Cell-to-Cell Transmission |
13:00-14:30 |
Lunch Break & Poster Session A |
|
S4. Structure and Mechanisms of Virus Replication (Part 2)chaired by Susana Guix |
||
| 14:30-15:00 | Ulrich Desselberger Invited Speaker |
Significance of Cellular Lipid Metabolism for the Replication of Rotaviruses and Other RNA Viruses |
| 15:00-15:15 | Diego Carlero Carnero | High-speed atomic force microscopy reveals real-time dynamics of influenza A virus transcription |
| 15:15-15:30 | Matteo Agostini | Dynamics of type I and III interferon responses against viral infections at single-cell resolution |
| 15:30-15:45 | Sainan Wang | Trans-complementation of functions of non-structural protein 1 of alphaviruses |
| 15:45-16:00 | Yong-Hui Zheng | MARCHF E3 ubiquitin ligases block furin proprotein convertase activity by a non-degradative mechanism via K33-linked polyubiquitination |
16:00-16:30 |
Coffee Break & Poster Session A |
|
S5. Virus-Host Interactions (Part 1)chaired by Alan Cochrane |
||
| 16:30-17:00 | Svetlana Folimonova Invited Speaker |
Understanding Superinfection Exclusion by an RNA Virus |
| 17:00-17:15 | Daniel DiMaio | A segment of human papillomavirus L2 capsid protein supports virus entry in a sequence-independent manner |
| 17:15-17:30 | Stephanie Salazar | Interferon-λ Induces a Neuron-specific Antiviral Response Against Alpha Herpesvirus Infection |
| 17:30-17:45 | Guigen Zhang | Interferon-inducible KLK13 Inhibits SARS-CoV-2 Cell Entry and Syncytia Formation via Proteolytic Cleavage of Spike Protein |
| 17:45-18:00 | Yu Cong | Discrepancy Between Immune Response of Green Monkey Survivors and Those That Succumbed After Large-Particle Aerosol Exposure to Nipah Virus Malaysia Strain (NiVM) |
| 18:00-18:15 | Diana Ribeiro | Wobble uridine transfer RNA modifications shape influenza A virus infection in a codon-dependent manner |
| 18:15-18:30 | Brianna Busscher | The Roles of Severe Acute Respiratory Syndrome Coronavirus 2 Accessory Protein ORF3a in NF-κB Activation and Tumor necrosis factor receptor-associated factor Binding |
20:30- |
Conference Dinner |
|
Day 3 – Friday, 16 February 2024
S5. Virus-Host Interactions (Part 2)chaired by Enzo Tramontano |
||
| 09:00-09:30 | Felicia Goodrum Invited Speaker |
The Interplay Between HCMV and Cellular Pathways Regulating Cholesterol |
| 09:30-09:45 | Jose Almendral Del Rio | A mouse parvovirus disrupting glioblastoma stem cell-based tumours through patient-specific p53 deregulations |
| 09:45-10:00 | Nikki Stark | The interactive effects of Wolbachia and Nop60B on Sindbis virus replication |
| 10:00-10:15 | Gabriel Guajardo-Contreras | HIV-1 alters late endosome/lysosome motility to assemble at virus-containing compartments in macrophages |
| 10:15-10:30 | Mireia Puig | Establishment of chronic Chikungunya infection in mosquito cells requires dynamic changes of the host and virus translation landscapes |
| 10:30-10:45 | Urtzi Garaigorta | Host factor Senataxin restricts DNA virus gene expression at the transcriptional level |
| 10:45-11:00 | John Casey | Interferon lambda mRNA synthesis is induced by double-stranded RNA produced during hepatitis delta virus replication |
11:00-11:30 |
Coffee Break |
|
S5. Virus-Host Interactions (Part 3)chaired by Jamil Saad |
||
| 11:30-12:00 | Felix Rey Invited Speaker |
The Class II Enveloped Viruses “Accompanying” Glycoprotein |
| 12:00-12:15 | Dong-Yan Jin | Promotion of SARS-CoV-2 replication by NSP1 mediated through activation of calcineurin-NFAT signaling |
| 12:15-12:30 | Jeanmarie Verchot | Bax inhibitor 1 (BI-1) and bZIP60 transcription factor regulate virus replication and cell-to-cell movement independently while integrating IRE1-led ER stress signaling |
| 12:30-12:45 | Taylor Caddell | Sarbecovirus Membrane Proteins Inhibit ATF6 Activation |
| 12:45-13:00 | Christine O'Connor | Host-encoded CTCF regulates HCMV latency via chromatin looping |
13:00-14:30 |
Lunch Break & Poster Session B |
|
S6. Viral Pathogenesis and Evolution (Part 1)chaired by Silvi Rouskin |
||
| 14:30-15:00 | Santiago Elena Invited Speaker |
Accumulation Dynamics of Defective Genomes During Experimental Evolution of Betacoronaviruses |
| 15:00-15:15 | Liani Coronado | Immune Checkpoint Activation With Metabolism and Immune Disfunctions During Lethal Classical Swine Fever Virus Infection |
| 15:15-15:30 | Gabriel Parra | Discordant Genetic and Antigenic Diversification of Norovirus GII.4 Sydney_2012 After a Decade of Circulation in Humans |
| 15:30-16:00 | Linda Saif Invited Speaker |
Evolving Coronaviruses: Spike Recombinants and Mutants Influence Intra/Interspecies Transmission and Virulence |
16:00-16:30 |
Coffee Break & Poster Session B |
|
S6. Viral Pathogenesis and Evolution (Part 2)chaired by Karen Mossman |
||
| 16:30-17:00 | Rosa M. Pinto Invited Speaker |
The Hepatocyte Traffic Network in the Hepatitis A Virus Infectious Cycle: An Evolutionary-Driven Use? |
| 17:00-17:15 | Samantha Cotsmire | Persistent SARS-CoV-2 infection in primary human small intestinal tissues as an in vitro model for characterizing long COVID |
| 17:15-17:30 | Ariana Arduini | Investigating the role of accessory protein ORF8 secretion in the pathogenesis of SARS-CoV-2 and its variants |
| 17:30-17:45 | Nathania Dabilla Alves Silva | Structure and Dynamics of Enterovirus Genotype Networks |
| 17:45-18:00 | Matthew Evans | Evolutionary pathways to resistance to Flavivirus STAT2 antagonism |
| 18:00-18:15 | Wilson Nguyen | Neurovirulence of the Australian outbreak Japanese Encephalitis virus genotype 4 is lower compared to genotypes 2 and 3 in mice and human cortical brain organoids |
| 18:15-18:30 | Nefert Candace Dossou | Unraveling the Measles Puzzle: Genotypes shifting Landscapes, Selection, and Recombinants |
18:30 |
Closing Ceremony / End of Conference |
|